DRAEGERWERK AG (DRW8.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:DRW8 - DE0005550602 - Common Stock
61.4 EUR
+2.8 (+4.78%)
Overall DRW8 gets a fundamental rating of 5 out of 10. We evaluated DRW8 against 63 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of DRW8 get a neutral evaluation. Nothing too spectacular is happening here. DRW8 is valued quite cheap, while showing a decent growth score. This is a good combination!
1. Profitability
1.1 Basic Checks
In the past year DRW8 was profitable.
DRW8 had a positive operating cash flow in the past year.
DRW8 had positive earnings in 4 of the past 5 years.
Of the past 5 years DRW8 4 years had a positive operating cash flow.
1.2 Ratios
The Return On Assets of DRW8 (3.99%) is comparable to the rest of the industry.
DRW8 has a Return On Equity of 8.02%. This is comparable to the rest of the industry: DRW8 outperforms 57.14% of its industry peers.
DRW8 has a better Return On Invested Capital (7.67%) than 65.08% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.99% | ||
| ROE | 8.02% | ||
| ROIC | 7.67% |
ROA(3y)1.84%
ROA(5y)3.09%
ROE(3y)3.69%
ROE(5y)7.99%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Profit Margin value of 3.54%, DRW8 perfoms like the industry average, outperforming 46.03% of the companies in the same industry.
In the last couple of years the Profit Margin of DRW8 has grown nicely.
With a Operating Margin value of 6.02%, DRW8 is not doing good in the industry: 61.90% of the companies in the same industry are doing better.
DRW8's Operating Margin has improved in the last couple of years.
DRW8 has a Gross Margin of 45.35%. This is in the lower half of the industry: DRW8 underperforms 66.67% of its industry peers.
In the last couple of years the Gross Margin of DRW8 has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.02% | ||
| PM (TTM) | 3.54% | ||
| GM | 45.35% |
OM growth 3Y-13.99%
OM growth 5Y11.88%
PM growth 3Y-2.93%
PM growth 5Y32.71%
GM growth 3Y-1.06%
GM growth 5Y0.96%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so DRW8 is still creating some value.
The number of shares outstanding for DRW8 has been reduced compared to 1 year ago.
The number of shares outstanding for DRW8 has been increased compared to 5 years ago.
DRW8 has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.67 indicates that DRW8 is not a great score, but indicates only limited risk for bankruptcy at the moment.
DRW8 has a Altman-Z score of 2.67. This is comparable to the rest of the industry: DRW8 outperforms 53.97% of its industry peers.
DRW8 has a debt to FCF ratio of 2.16. This is a good value and a sign of high solvency as DRW8 would need 2.16 years to pay back of all of its debts.
DRW8 has a better Debt to FCF ratio (2.16) than 79.37% of its industry peers.
A Debt/Equity ratio of 0.10 indicates that DRW8 is not too dependend on debt financing.
DRW8 has a better Debt to Equity ratio (0.10) than 76.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 2.16 | ||
| Altman-Z | 2.67 |
ROIC/WACC1.18
WACC6.5%
2.3 Liquidity
DRW8 has a Current Ratio of 1.76. This is a normal value and indicates that DRW8 is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.76, DRW8 perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
DRW8 has a Quick Ratio of 1.03. This is a normal value and indicates that DRW8 is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.03, DRW8 perfoms like the industry average, outperforming 46.03% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.76 | ||
| Quick Ratio | 1.03 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 6.68% over the past year.
Measured over the past years, DRW8 shows a very strong growth in Earnings Per Share. The EPS has been growing by 36.42% on average per year.
DRW8 shows a small growth in Revenue. In the last year, the Revenue has grown by 2.14%.
DRW8 shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.92% yearly.
EPS 1Y (TTM)6.68%
EPS 3Y-2.51%
EPS 5Y36.42%
EPS Q2Q%143.82%
Revenue 1Y (TTM)2.14%
Revenue growth 3Y0.42%
Revenue growth 5Y3.92%
Sales Q2Q%7.58%
3.2 Future
The Earnings Per Share is expected to grow by 7.93% on average over the next years.
The Revenue is expected to grow by 3.15% on average over the next years.
EPS Next Y5.11%
EPS Next 2Y10.82%
EPS Next 3Y11.88%
EPS Next 5Y7.93%
Revenue Next Year2.9%
Revenue Next 2Y3.54%
Revenue Next 3Y3.68%
Revenue Next 5Y3.15%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 9.52 indicates a reasonable valuation of DRW8.
Based on the Price/Earnings ratio, DRW8 is valued cheaper than 100.00% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.76. DRW8 is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 8.41, which indicates a very decent valuation of DRW8.
Based on the Price/Forward Earnings ratio, DRW8 is valued cheaper than 95.24% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.96, DRW8 is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.52 | ||
| Fwd PE | 8.41 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, DRW8 is valued cheaply inside the industry as 96.83% of the companies are valued more expensively.
DRW8's Price/Free Cash Flow ratio is rather cheap when compared to the industry. DRW8 is cheaper than 98.41% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.42 | ||
| EV/EBITDA | 3.36 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates DRW8 does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)1.86
PEG (5Y)0.26
EPS Next 2Y10.82%
EPS Next 3Y11.88%
5. Dividend
5.1 Amount
DRW8 has a Yearly Dividend Yield of 3.23%.
DRW8's Dividend Yield is rather good when compared to the industry average which is at 2.14. DRW8 pays more dividend than 93.65% of the companies in the same industry.
DRW8's Dividend Yield is a higher than the S&P500 average which is at 2.31.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.23% |
5.2 History
On average, the dividend of DRW8 grows each year by 51.02%, which is quite nice.
Dividend Growth(5Y)51.02%
Div Incr Years2
Div Non Decr Years4
5.3 Sustainability
DRW8 pays out 31.13% of its income as dividend. This is a sustainable payout ratio.
DRW8's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP31.13%
EPS Next 2Y10.82%
EPS Next 3Y11.88%
FRA:DRW8 (12/11/2025, 7:00:00 PM)
61.4
+2.8 (+4.78%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners10.23%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.15B
Revenue(TTM)3.42B
Net Income(TTM)120.88M
Analysts81.33
Price Target82.49 (34.35%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.23% |
Yearly Dividend1.77
Dividend Growth(5Y)51.02%
DP31.13%
Div Incr Years2
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.24%
PT rev (3m)13.55%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)2.21%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.39%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.52 | ||
| Fwd PE | 8.41 | ||
| P/S | 0.34 | ||
| P/FCF | 8.42 | ||
| P/OCF | 5.68 | ||
| P/B | 0.76 | ||
| P/tB | 0.99 | ||
| EV/EBITDA | 3.36 |
EPS(TTM)6.45
EY10.5%
EPS(NY)7.3
Fwd EY11.89%
FCF(TTM)7.29
FCFY11.88%
OCF(TTM)10.82
OCFY17.62%
SpS182.27
BVpS80.37
TBVpS62.21
PEG (NY)1.86
PEG (5Y)0.26
Graham Number108
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.99% | ||
| ROE | 8.02% | ||
| ROCE | 10.2% | ||
| ROIC | 7.67% | ||
| ROICexc | 8.64% | ||
| ROICexgc | 10.67% | ||
| OM | 6.02% | ||
| PM (TTM) | 3.54% | ||
| GM | 45.35% | ||
| FCFM | 4% |
ROA(3y)1.84%
ROA(5y)3.09%
ROE(3y)3.69%
ROE(5y)7.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-18.01%
ROICexgc growth 5Y12.44%
ROICexc growth 3Y-16.98%
ROICexc growth 5Y13.06%
OM growth 3Y-13.99%
OM growth 5Y11.88%
PM growth 3Y-2.93%
PM growth 5Y32.71%
GM growth 3Y-1.06%
GM growth 5Y0.96%
F-Score7
Asset Turnover1.13
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 2.16 | ||
| Debt/EBITDA | 0.44 | ||
| Cap/Depr | 44.92% | ||
| Cap/Sales | 1.93% | ||
| Interest Coverage | 11.48 | ||
| Cash Conversion | 57.51% | ||
| Profit Quality | 113.22% | ||
| Current Ratio | 1.76 | ||
| Quick Ratio | 1.03 | ||
| Altman-Z | 2.67 |
F-Score7
WACC6.5%
ROIC/WACC1.18
Cap/Depr(3y)46.64%
Cap/Depr(5y)59.31%
Cap/Sales(3y)2.11%
Cap/Sales(5y)2.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.68%
EPS 3Y-2.51%
EPS 5Y36.42%
EPS Q2Q%143.82%
EPS Next Y5.11%
EPS Next 2Y10.82%
EPS Next 3Y11.88%
EPS Next 5Y7.93%
Revenue 1Y (TTM)2.14%
Revenue growth 3Y0.42%
Revenue growth 5Y3.92%
Sales Q2Q%7.58%
Revenue Next Year2.9%
Revenue Next 2Y3.54%
Revenue Next 3Y3.68%
Revenue Next 5Y3.15%
EBIT growth 1Y12.74%
EBIT growth 3Y-13.63%
EBIT growth 5Y16.27%
EBIT Next Year83.6%
EBIT Next 3Y27.93%
EBIT Next 5Y13.46%
FCF growth 1Y20.52%
FCF growth 3Y-27.65%
FCF growth 5Y0.28%
OCF growth 1Y11.8%
OCF growth 3Y-24.25%
OCF growth 5Y0.35%
DRAEGERWERK AG / DRW8.DE FAQ
Can you provide the ChartMill fundamental rating for DRAEGERWERK AG?
ChartMill assigns a fundamental rating of 5 / 10 to DRW8.DE.
What is the valuation status for DRW8 stock?
ChartMill assigns a valuation rating of 7 / 10 to DRAEGERWERK AG (DRW8.DE). This can be considered as Undervalued.
What is the profitability of DRW8 stock?
DRAEGERWERK AG (DRW8.DE) has a profitability rating of 4 / 10.
What are the PE and PB ratios of DRAEGERWERK AG (DRW8.DE) stock?
The Price/Earnings (PE) ratio for DRAEGERWERK AG (DRW8.DE) is 9.52 and the Price/Book (PB) ratio is 0.76.
Can you provide the expected EPS growth for DRW8 stock?
The Earnings per Share (EPS) of DRAEGERWERK AG (DRW8.DE) is expected to grow by 5.11% in the next year.